125 related articles for article (PubMed ID: 2084630)
1. [Azole derivatives--new drugs in the treatment of mycoses].
Gwieździński Z; Urbanowski S
Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):740-4. PubMed ID: 2084630
[No Abstract] [Full Text] [Related]
2. Management of drug and food interactions with azole antifungal agents in transplant recipients.
Dodds-Ashley E
Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
[TBL] [Abstract][Full Text] [Related]
3. The evolution of azole compounds in antifungal chemotherapy.
Borgers M
J Chemother; 1989 Jul; 1(4 Suppl):238-40. PubMed ID: 16312384
[No Abstract] [Full Text] [Related]
4. [Clinical importance of azoles in antifungal therapy: treatment or prophylaxis with new azoles in hematology].
Vazquez Lopez L
Rev Esp Quimioter; 2004 Mar; 17(1):98-100. PubMed ID: 15201932
[No Abstract] [Full Text] [Related]
5. Recent approaches to antifungal therapy for invasive mycoses.
Mathew BP; Nath M
ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
[TBL] [Abstract][Full Text] [Related]
6. Azole antimycotics--a highway to new drugs or a dead end?
Musiol R; Kowalczyk W
Curr Med Chem; 2012; 19(9):1378-88. PubMed ID: 22257053
[TBL] [Abstract][Full Text] [Related]
7. Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?
Hof H
Drug Resist Updat; 2008; 11(1-2):25-31. PubMed ID: 18325827
[TBL] [Abstract][Full Text] [Related]
8. Antifungal drugs.
Treat Guidel Med Lett; 2005 Feb; 3(30):7-14. PubMed ID: 15671963
[No Abstract] [Full Text] [Related]
9. [Azoles: Prophylactic or therapeutic?].
Jarque I
Rev Esp Quimioter; 2004 Mar; 17(1):94-7. PubMed ID: 15201931
[No Abstract] [Full Text] [Related]
10. [Clinical-microbiological correlation in patients treated with azoles].
Quereda Rodriguez Navarro C
Rev Esp Quimioter; 2004 Mar; 17(1):91-3. PubMed ID: 15201930
[No Abstract] [Full Text] [Related]
11. New azoles as first line therapy for Paecilomyces lilacinus in transplant patients.
Garzoni C; Garbino J
Transpl Infect Dis; 2008 Apr; 10(2):149-50. PubMed ID: 18353095
[No Abstract] [Full Text] [Related]
12. Introduction to antifungal drugs.
Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):653-7. PubMed ID: 10770726
[No Abstract] [Full Text] [Related]
13. Antifungal drugs.
Treat Guidel Med Lett; 2008 Jan; 6(65):1-8. PubMed ID: 18157085
[No Abstract] [Full Text] [Related]
14. The biology and chemistry of antifungal agents: a review.
Kathiravan MK; Salake AB; Chothe AS; Dudhe PB; Watode RP; Mukta MS; Gadhwe S
Bioorg Med Chem; 2012 Oct; 20(19):5678-98. PubMed ID: 22902032
[TBL] [Abstract][Full Text] [Related]
15. [Antimycotic therapy].
Schaffner A
Ther Umsch; 1990 Aug; 47(8):664-9. PubMed ID: 2218968
[TBL] [Abstract][Full Text] [Related]
16. Use of amphotericin B with azole antifungal drugs: what are we doing?
Sugar AM
Antimicrob Agents Chemother; 1995 Sep; 39(9):1907-12. PubMed ID: 8540690
[No Abstract] [Full Text] [Related]
17. New antifungal agents in pediatric practice.
Das S; Shivaprakash MR; Chakrabarti A
Indian Pediatr; 2009 Mar; 46(3):225-31. PubMed ID: 19346570
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between structure and function in the azoles].
Sádaba B; García Quetglas E; Azanza JR
Rev Esp Quimioter; 2004 Mar; 17(1):71-8. PubMed ID: 15201927
[No Abstract] [Full Text] [Related]
19. Antifungal azoles: old and new.
Blyth CC
Pediatr Infect Dis J; 2011 Jun; 30(6):506-7. PubMed ID: 21587027
[No Abstract] [Full Text] [Related]
20. [Azole antifungal agents in the prevention of fungal infections in neutropenic patients and bone marrow graft recipients].
Lortholary O; Dupont B
Ann Med Interne (Paris); 1997; 148(3):258-67. PubMed ID: 9255336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
